Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
12/1998
12/09/1998EP0882796A2 Nucleic acid molecules encoding Streptococcus pneumoniae rnc protein, and compositions comprising the same
12/09/1998EP0882793A2 A human 7-tm receptor similar to murine frizzled-6 gene
12/09/1998EP0882791A2 WNT-11 polypeptides
12/09/1998EP0882453A2 Methods for treating thrombotic disorders
12/09/1998EP0882451A1 Glycine for prevention or treatment of transplant rejection
12/09/1998EP0882130A2 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same
12/09/1998EP0882128A1 Cell-based assay
12/09/1998EP0882029A1 Heterocyclic derivatives as antidiabetic and antiobesity agents
12/09/1998EP0882024A1 Retroviral protease inhibiting compounds
12/09/1998EP0882010A1 Pharmaceutical agents containing perfluoroalkyl-containing metal complexes and the use thereof in tumour therapy and interventional radiology
12/09/1998EP0881912A1 Use of angiogenic lipids for vascularizing tissue
12/09/1998EP0881908A1 Use of fibroblast growth factors to stimulate bone growth
12/09/1998EP0881905A1 Urogenital and intestinal disorder compositions comprising a substance derived from plant species of the ericaceae family and a lactic acid bacteria growth factor
12/09/1998EP0881900A1 Use of leukotriene b 4? or its analogues as antiviral and antineoplastic agents
12/09/1998CN1201395A Method for treatment of helicobacter pylori infections
12/09/1998CN1201390A 5-HT3 receptor antagonists for treating dyskinesia
12/09/1998CN1201389A Method and pharmaceutical composition for regulating lipid concentration
12/09/1998CN1201386A Microemlsions used as carriers for administration of active compounds
12/09/1998CN1201385A Therapeutic preparation for transdermal administration of active substances
12/09/1998CN1201384A Aerosol compositions
12/09/1998CN1041091C Trisubstituted pyrimido (5,4-d) pyrimidines for modulating multi-medicine resistance, medicinal composition containing said compound and preparation
12/08/1998US5847164 Method for the preparation of chromanone 7
12/08/1998US5847093 Human apoptosis regulator
12/08/1998US5847010 Treatment of multiple sclerosis
12/08/1998US5847008 Method of treating diabetes and related disease states
12/08/1998US5847007 Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
12/08/1998US5847004 Method for in vivo reduction of nitric oxide levels and compositions useful therefor
12/08/1998US5847003 Oxa acids and related compounds for treating skin conditions
12/08/1998US5847002 Compositions, for inhibition, control and regression of angiogenesis, containing hyaluronic acid and NSAID
12/08/1998US5846987 Retroviral protease inhibiting compounds
12/08/1998US5846978 HIV protease inhibitors useful for the treatment of AIDS
12/08/1998US5846961 Multi-faceted method to repress reproduction of latent viruses in humans and animals
12/08/1998US5846959 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
12/08/1998US5846755 Method for determining the therapeutic activity of metalloproteinase inhibitor compounds
12/08/1998US5846565 Controlled local delivery of chemotherapeutic agents for treating solid tumors
12/08/1998US5846548 Combined administration of mitogenic immumo stimulator and a thymomimetic
12/08/1998US5846528 Treating anemia using recombinant adeno-associated virus virions comprising an EPO DNA sequence
12/08/1998CA2073180C Therapeutic uses of melanin
12/05/1998CA2233591A1 Novel compounds
12/04/1998CA2233590A1 Novel compounds
12/03/1998WO1998054821A1 Brush holder
12/03/1998WO1998054365A1 Control of immune responses by modulating activity of glycosyltransferases
12/03/1998WO1998054321A1 New human dp1 homolog
12/03/1998WO1998054316A1 Sodium channel receptor
12/03/1998WO1998054312A1 Ribosome complexes as selection particles for in vitro display and evolution of proteins
12/03/1998WO1998054203A1 Inhibition of stress activated protein kinase (sapk) pathway and sensitization of cells to cancer therapies
12/03/1998WO1998054202A1 Human tumor necrosis factor receptor tr10
12/03/1998WO1998053876A1 Electrically activated substance and method for making the same
12/03/1998WO1998053856A1 Methods for the detection, treatment, and prevention of neurodegeneration
12/03/1998WO1998053853A1 Combined product associating a nucleic acid with a substance breaking up the extracellular matrix for gene therapy
12/03/1998WO1998053850A2 Compositions and means for the treatment of burns and other cutaneous traumas
12/03/1998WO1998053846A1 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
12/03/1998WO1998053840A1 SIALOADHESIN FAMILY 4 cDNA
12/03/1998WO1998053839A2 Anti-cancer products for treating cystic fibrosis
12/03/1998WO1998053806A1 Medicinal compositions for topical administration containing vitamin d and vitamin k
12/03/1998WO1998053698A1 Uses of oil bodies
12/03/1998WO1998041238A3 Methods and kits for treating and diagnosing leiomyomas
12/03/1998WO1998040375A3 COMBINATION OF ILEAL BILE ACID TRANSPORT INHIBITING BENZOTHIEPINES AND HMG Co-A REDUCTASE INHIBITORS
12/03/1998DE19719652A1 Use of tissue factor
12/03/1998CA2292790A1 Human tumor necrosis factor receptor tr10
12/03/1998CA2291590A1 Combined product associating a nucleic acid with a substance breaking up the extracellular matrix for gene therapy
12/03/1998CA2291451A1 Inhibition of stress activated protein kinase (sapk) pathway and sensitization of cells to cancer therapies
12/03/1998CA2291258A1 Inhibitors of naaladase enzyme activity
12/03/1998CA2290943A1 New human dp1 homolog
12/02/1998EP0881300A2 Method for identifying compounds for inhibition of neoplastic lesions
12/02/1998EP0881297A2 Histidine kinase
12/02/1998EP0881295A2 Histidine kinase
12/02/1998EP0881294A2 HOEFCC11, a HAS2 splicing variant
12/02/1998EP0881292A2 Streptocococcus pneumoniae peptide release factor
12/02/1998EP0881289A2 Novel 7TM receptor (H2CAA71)
12/02/1998EP0880964A2 Aldose reductase inhibition in preventing or reversing diabetic cardiomyopathy
12/02/1998EP0880597A1 THERAPEUTIC APPLICATIONS FOR THE ANTI-T-BAM (CD40-L) MONOCLONAL ANTIBODY 5c8
12/02/1998EP0880364A2 Contraceptive release systems with antibacterial and/or antiviral effect
12/02/1998EP0880363A1 Combinations, having immunosuppressive effects, containing a cyclooxygenase-2 inhibitor and a leukotriene a 4? hydrolase inhibitor
12/02/1998EP0880362A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b 4 receptor antagonist
12/02/1998EP0880353A1 Compositions and methods for modulating melanin production
12/02/1998EP0869975A4 Assay for and uses of peptide hormone receptor ligands
12/02/1998EP0583358B1 Partial liquid breathing of fluorocarbons
12/02/1998CN1200674A Establishment of TONIC ovarian estrogen secretion for extended therapeutic regimens
12/02/1998CN1200672A Pharmaceutical formulation
12/02/1998CA2230963A1 A human 7-tm receptor similar to murine frizzled-6 gene
12/01/1998US5844074 Cyclic CRF agonists
12/01/1998US5843998 Skin blemish treatment
12/01/1998US5843994 Compositions and methods for treating and preventing pathologies including cancer
12/01/1998US5843961 Method and composition for treating erectile dysfunction
12/01/1998US5843960 Inhibitors of rotamase enzyme activity
12/01/1998US5843727 Polynucleotides encoding a human tumor-associated membrane protein
12/01/1998US5843719 Cellubrevin homolog
12/01/1998US5843675 TNF receptor death domain ligand proteins and inhibitors of ligand binding
12/01/1998US5843481 Treatment of proliferative disorders, metastasaes, and drug resistant tumors with vanadate compounds and derivatives or analogues thereof
12/01/1998US5843465 Emulsion formulation
12/01/1998US5843439 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
12/01/1998US5843438 Peripheralization of hematopoietic stem cells
12/01/1998US5843435 Immunotherapy of cancer with allogeneic lymphocytes
11/1998
11/30/1998CA2233580A1 Histidine kinase
11/30/1998CA2233577A1 Histidine kinase
11/30/1998CA2233539A1 Histidine kinase
11/29/1998CA2233561A1 Novel compounds
11/29/1998CA2231723A1 Novel has2 splicing variant hoefc11: a target in chronic renal failure, inflammatory diseases and myocardial schemia
11/27/1998CA2232817A1 Novel compounds
1 ... 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 ... 1151